Article Details

Seasonal Allergic Rhinitis Market to Reach US$ 14.1 Billion by 2034, Impelled by ... - BioSpace

Retrieved on: 2024-07-30 13:52:44

Tags for this article:

Click the tags to see associated articles and topics

Seasonal Allergic Rhinitis Market to Reach US$ 14.1 Billion by 2034, Impelled by ... - BioSpace. View article details on hiswai:

Excerpt

One notable instance of these advancements is the use of monoclonal antibodies, such as omalizumab (Xolair). Omalizumab targets immunoglobulin E ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo